PYRIDOPYRIMIDINES AS HISTAMINE H4-RECEPTOR INHIBITORS

The invention relates to compounds of formula (I):or pharmaceutically acceptable sails or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor.

Saved in:
Bibliographic Details
Main Authors OLIVERA, TIZNE, ROBERTO, HERNÁNDEZ, HERRERO, GONZALO, GARCÍA, DOMÍNGUEZ, NEFTALÍ, CORCÓSTEGUI, VIVAR, REYES, NOVERGES, PEDRO, BÁRBARA, ZAZPE, ARCE, ARTURO, TATO, CERDEIRAS, PALOMA
Format Patent
LanguageEnglish
Serbian
Published 30.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to compounds of formula (I):or pharmaceutically acceptable sails or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor.
Bibliography:Application Number: RS2022P000940